 | • レポートコード：QY20ST-10133 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の腎性貧血治療市場について種類別（鉄サプリメント、赤血球刺激剤）、用途別（Hospital、 Pharmacy、 Research Institute、 Other）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・腎性貧血治療市場の概要 ・世界の主要地域別腎性貧血治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の腎性貧血治療市場規模2015-2026：種類別（鉄サプリメント、赤血球刺激剤） ・世界の腎性貧血治療市場規模2015-2026：用途別（Hospital、 Pharmacy、 Research Institute、 Other） ・腎性貧血治療の北米市場規模2015-2020 ・腎性貧血治療のヨーロッパ市場規模2015-2020 ・腎性貧血治療の中国市場規模2015-2020 ・腎性貧血治療の日本市場規模2015-2020 ・腎性貧血治療の東南アジア市場規模2015-2020 ・腎性貧血治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・腎性貧血治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・腎性貧血治療の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Renal Anemia Treatment Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Renal Anemia Treatment market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Anemia is a common complication of CKD, typically occurring early in the development of the disease and becoming more severe as CKD progresses. The primary treatment goal in renal anemia is to increase and maintain hemoglobin and other anemia parameters, such as ferritin.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Renal Anemia Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Renal Anemia Treatment industry.
Based on our recent survey, we have several different scenarios about the Renal Anemia Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Renal Anemia Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Renal Anemia Treatment market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Renal Anemia Treatment market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Renal Anemia Treatment market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Renal Anemia Treatment market. The report also includes nautical information, where it shows Renal Anemia Treatment market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Renal Anemia Treatment market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Renal Anemia Treatment market.
Geographical Analysis:
Based on region, the global Renal Anemia Treatment market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Renal Anemia Treatment market are
Amgen Inc.
F. Hoffmann-La Roche Ltd
Pfizer Inc.
Novartis AG
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
AMAG Pharmaceuticals
Rockwell Medical
Akebia Therapeutics
Vifor Pharma Management Ltd.
Segment by Type
Iron Supplements
Erythrocyte Stimulating Agents
Segment by Application
Hospital
Pharmacy
Research Institute
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Renal Anemia Treatment market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Renal Anemia Treatment market.
• The market share of the global Renal Anemia Treatment market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Renal Anemia Treatment market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Renal Anemia Treatment market.
1 Renal Anemia Treatment Market Overview
1.1 Renal Anemia Treatment Product Scope
1.2 Renal Anemia Treatment Segment by Type
1.2.1 Global Renal Anemia Treatment Sales by Type (2020-2026)
1.2.2 Iron Supplements
1.2.3 Erythrocyte Stimulating Agents
1.3 Renal Anemia Treatment Segment by Application
1.3.1 Global Renal Anemia Treatment Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Research Institute
1.3.5 Other
1.4 Renal Anemia Treatment Market Estimates and Forecasts (2015-2026)
1.4.1 Global Renal Anemia Treatment Sales Growth Rate (2015-2026)
1.4.2 Global Renal Anemia Treatment Revenue and Growth Rate (2015-2026)
1.4.3 Global Renal Anemia Treatment Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Renal Anemia Treatment Industry Impact
1.5.1 How the Covid-19 is Affecting the Renal Anemia Treatment Industry
1.5.1.1 Renal Anemia Treatment Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Renal Anemia Treatment Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Renal Anemia Treatment Players to Combat Covid-19 Impact
2 Renal Anemia Treatment Estimate and Forecast by Region
2.1 Global Renal Anemia Treatment Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Renal Anemia Treatment Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Renal Anemia Treatment Sales Market Share by Region (2015-2020)
2.2.2 Global Renal Anemia Treatment Revenue Market Share by Region (2015-2020)
2.3 Global Renal Anemia Treatment Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Renal Anemia Treatment Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Renal Anemia Treatment Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Renal Anemia Treatment Estimates and Projections (2015-2026)
2.4.2 Europe Renal Anemia Treatment Estimates and Projections (2015-2026)
2.4.3 China Renal Anemia Treatment Estimates and Projections (2015-2026)
2.4.4 Japan Renal Anemia Treatment Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Renal Anemia Treatment Estimates and Projections (2015-2026)
2.4.6 India Renal Anemia Treatment Estimates and Projections (2015-2026)
3 Global Renal Anemia Treatment Competition Landscape by Players
3.1 Global Top Renal Anemia Treatment Players by Sales (2015-2020)
3.2 Global Top Renal Anemia Treatment Players by Revenue (2015-2020)
3.3 Global Renal Anemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Anemia Treatment as of 2019)
3.4 Global Renal Anemia Treatment Average Price by Company (2015-2020)
3.5 Manufacturers Renal Anemia Treatment Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Renal Anemia Treatment Players (Opinion Leaders)
4 Global Renal Anemia Treatment Market Size by Type
4.1 Global Renal Anemia Treatment Historic Market Review by Type (2015-2020)
4.1.1 Global Renal Anemia Treatment Sales Market Share by Type (2015-2020)
4.1.2 Global Renal Anemia Treatment Revenue Market Share by Type (2015-2020)
4.1.3 Global Renal Anemia Treatment Price by Type (2014-2020)
4.2 Global Renal Anemia Treatment Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Renal Anemia Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Renal Anemia Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Global Renal Anemia Treatment Price Forecast by Type (2021-2026)
5 Global Renal Anemia Treatment Market Size by Application
5.1 Global Renal Anemia Treatment Historic Market Review by Application (2015-2020)
5.1.1 Global Renal Anemia Treatment Sales Market Share by Application (2015-2020)
5.1.2 Global Renal Anemia Treatment Revenue Market Share by Application (2015-2020)
5.1.3 Global Renal Anemia Treatment Price by Application (2015-2020)
5.2 Global Renal Anemia Treatment Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Renal Anemia Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Renal Anemia Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Renal Anemia Treatment Price Forecast by Application (2021-2026)
3 North America Renal Anemia Treatment Market Facts & Figures
3.2 North America Renal Anemia Treatment Sales Market Share by Company (2015-2020)
3.3 North America Renal Anemia Treatment Sales Market Share by Type (2015-2020)
3.4 North America Renal Anemia Treatment Sales Market Share by Application (2015-2020)
4 Europe Renal Anemia Treatment Market Facts & Figures
4.2 Europe Renal Anemia Treatment Sales Market Share by Company (2015-2020)
4.3 Europe Renal Anemia Treatment Sales Market Share by Type (2015-2020)
4.4 Europe Renal Anemia Treatment Sales Market Share by Application (2015-2020)
5 China Renal Anemia Treatment Market Facts & Figures
5.2 China Renal Anemia Treatment Sales Market Share by Company (2015-2020)
5.3 China Renal Anemia Treatment Sales Market Share by Type (2015-2020)
5.4 China Renal Anemia Treatment Sales Market Share by Application (2015-2020)
6 Japan Renal Anemia Treatment Market Facts & Figures
6.2 Japan Renal Anemia Treatment Sales Market Share by Company (2015-2020)
6.3 Japan Renal Anemia Treatment Sales Market Share by Type (2015-2020)
6.4 Japan Renal Anemia Treatment Sales Market Share by Application (2015-2020)
7 Southeast Asia Renal Anemia Treatment Market Facts & Figures
7.2 Southeast Asia Renal Anemia Treatment Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Renal Anemia Treatment Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Renal Anemia Treatment Sales Market Share by Application (2015-2020)
8 India Renal Anemia Treatment Market Facts & Figures
8.2 India Renal Anemia Treatment Sales Market Share by Company (2015-2020)
8.3 India Renal Anemia Treatment Sales Market Share by Type (2015-2020)
8.4 India Renal Anemia Treatment Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Renal Anemia Treatment Business
12.1 Amgen Inc.
12.1.1 Amgen Inc. Renal Anemia Treatment Corporation Information
12.1.2 Amgen Inc. Renal Anemia Treatment Business Overview and Total Revenue
12.1.3 Amgen Inc. Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen Inc. Renal Anemia Treatment Products Offered
12.1.5 Amgen Inc. Recent Development
12.2 F. Hoffmann-La Roche Ltd
12.2.1 F. Hoffmann-La Roche Ltd Renal Anemia Treatment Corporation Information
12.2.2 F. Hoffmann-La Roche Ltd Renal Anemia Treatment Business Overview and Total Revenue
12.2.3 F. Hoffmann-La Roche Ltd Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.2.4 F. Hoffmann-La Roche Ltd Renal Anemia Treatment Products Offered
12.2.5 F. Hoffmann-La Roche Ltd Recent Development
12.3 Pfizer Inc.
12.3.1 Pfizer Inc. Renal Anemia Treatment Corporation Information
12.3.2 Pfizer Inc. Renal Anemia Treatment Business Overview and Total Revenue
12.3.3 Pfizer Inc. Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Inc. Renal Anemia Treatment Products Offered
12.3.5 Pfizer Inc. Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Renal Anemia Treatment Corporation Information
12.4.2 Novartis AG Renal Anemia Treatment Business Overview and Total Revenue
12.4.3 Novartis AG Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis AG Renal Anemia Treatment Products Offered
12.4.5 Novartis AG Recent Development
12.5 Johnson & Johnson Services Inc.
12.5.1 Johnson & Johnson Services Inc. Renal Anemia Treatment Corporation Information
12.5.2 Johnson & Johnson Services Inc. Renal Anemia Treatment Business Overview and Total Revenue
12.5.3 Johnson & Johnson Services Inc. Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Services Inc. Renal Anemia Treatment Products Offered
12.5.5 Johnson & Johnson Services Inc. Recent Development
12.6 Teva Pharmaceutical Industries Ltd.
12.6.1 Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Corporation Information
12.6.2 Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Business Overview and Total Revenue
12.6.3 Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Products Offered
12.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.7 AMAG Pharmaceuticals
12.7.1 AMAG Pharmaceuticals Renal Anemia Treatment Corporation Information
12.7.2 AMAG Pharmaceuticals Renal Anemia Treatment Business Overview and Total Revenue
12.7.3 AMAG Pharmaceuticals Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.7.4 AMAG Pharmaceuticals Renal Anemia Treatment Products Offered
12.7.5 AMAG Pharmaceuticals Recent Development
12.8 Rockwell Medical
12.8.1 Rockwell Medical Renal Anemia Treatment Corporation Information
12.8.2 Rockwell Medical Renal Anemia Treatment Business Overview and Total Revenue
12.8.3 Rockwell Medical Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Rockwell Medical Renal Anemia Treatment Products Offered
12.8.5 Rockwell Medical Recent Development
12.9 Akebia Therapeutics
12.9.1 Akebia Therapeutics Renal Anemia Treatment Corporation Information
12.9.2 Akebia Therapeutics Renal Anemia Treatment Business Overview and Total Revenue
12.9.3 Akebia Therapeutics Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Akebia Therapeutics Renal Anemia Treatment Products Offered
12.9.5 Akebia Therapeutics Recent Development
12.10 Vifor Pharma Management Ltd.
12.10.1 Vifor Pharma Management Ltd. Renal Anemia Treatment Corporation Information
12.10.2 Vifor Pharma Management Ltd. Renal Anemia Treatment Business Overview and Total Revenue
12.10.3 Vifor Pharma Management Ltd. Renal Anemia Treatment Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Vifor Pharma Management Ltd. Renal Anemia Treatment Products Offered
12.10.5 Vifor Pharma Management Ltd. Recent Development
13 Renal Anemia Treatment Manufacturing Cost Analysis
13.1 Renal Anemia Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Renal Anemia Treatment
13.4 Renal Anemia Treatment Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Renal Anemia Treatment Distributors List
14.3 Renal Anemia Treatment Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Renal Anemia Treatment Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Renal Anemia Treatment Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Renal Anemia Treatment Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Renal Anemia Treatment Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Renal Anemia Treatment Players to Combat Covid-19 Impact
Table 8. Global Market Renal Anemia Treatment Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Renal Anemia Treatment Sales (MT) by Region (2015-2020)
Table 10. Global Renal Anemia Treatment Sales Market Share by Region (2015-2020)
Table 11. Global Renal Anemia Treatment Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Renal Anemia Treatment Revenue Share by Region (2015-2020)
Table 13. Global Renal Anemia Treatment Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Renal Anemia Treatment Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Renal Anemia Treatment Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Renal Anemia Treatment Revenue Share Forecast by Region (2021-2026)
Table 17. Global Renal Anemia Treatment (MT) of Key Companies (2015-2020)
Table 18. Global Renal Anemia Treatment Sales Share by Company (2015-2020)
Table 19. Global Renal Anemia Treatment Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Renal Anemia Treatment Revenue Share by Company (2015-2020)
Table 21. Global Renal Anemia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Anemia Treatment as of 2019)
Table 22. Global Renal Anemia Treatment Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Renal Anemia Treatment Manufacturing Sites and Area Served
Table 24. Manufacturers Renal Anemia Treatment Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Renal Anemia Treatment Players
Table 27. Global Renal Anemia Treatment Sales (MT) by Type (2015-2020)
Table 28. Global Renal Anemia Treatment Sales Share by Type (2015-2020)
Table 29. Global Renal Anemia Treatment Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Renal Anemia Treatment Price (MT) by Type (2015-2020)
Table 31. Global Renal Anemia Treatment Sales Share by Type (2021-2026)
Table 32. Global Renal Anemia Treatment Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Renal Anemia Treatment Revenue Share by Type (2021-2026)
Table 34. Global Renal Anemia Treatment Price (MT) by Type (2021-2026)
Table 35. Global Renal Anemia Treatment Sales (MT) by Application (2015-2020)
Table 36. Global Renal Anemia Treatment Sales Share by Application (2015-2020)
Table 37. Global Renal Anemia Treatment Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Renal Anemia Treatment Price (MT) by Application (2015-2020)
Table 39. Global Renal Anemia Treatment Sales (MT) by Application (2021-2026)
Table 40. Global Renal Anemia Treatment Sales Share by Application (2021-2026)
Table 41. Global Renal Anemia Treatment Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Renal Anemia Treatment Revenue Share by Application (2021-2026)
Table 43. Global Renal Anemia Treatment Price (MT) by Application (2021-2026)
Table 44. United States Renal Anemia Treatment Sales (MT) by Company (2015-2020)
Table 45. United States Renal Anemia Treatment Sales Market Share by Company (2015-2020)
Table 46. United States Renal Anemia Treatment Sales (MT) by Type (2015-2020)
Table 47. United States Renal Anemia Treatment Sales Market Share by Type (2015-2020)
Table 48. United States Renal Anemia Treatment Sales (MT) by Application (2015-2020)
Table 49. United States Renal Anemia Treatment Sales Market Share by Application (2015-2020)
Table 50. Europe Renal Anemia Treatment Sales (MT) by Company (2015-2020)
Table 51. Europe Renal Anemia Treatment Sales Market Share by Company (2015-2020)
Table 52. Europe Renal Anemia Treatment Sales (MT) by Type (2015-2020)
Table 53. Europe Renal Anemia Treatment Sales Market Share by Type (2015-2020)
Table 54. Europe Renal Anemia Treatment Sales (MT) by Application (2015-2020)
Table 55. Europe Renal Anemia Treatment Sales Market Share by Type (2015-2020)
Table 56. China Renal Anemia Treatment Sales (MT) by Company (2015-2020)
Table 57. China Renal Anemia Treatment Sales Market Share by Company (2015-2020)
Table 58. China Renal Anemia Treatment Sales (MT) by Type (2015-2020)
Table 59. China Renal Anemia Treatment Sales Market Share by Type (2015-2020)
Table 60. China Renal Anemia Treatment Sales (MT) by Application (2015-2020)
Table 61. China Renal Anemia Treatment Sales Market Share by Application (2015-2020)
Table 62. Japan Renal Anemia Treatment Sales (MT) by Company (2015-2020)
Table 63. Japan Renal Anemia Treatment Sales Market Share by Company (2015-2020)
Table 64. Japan Renal Anemia Treatment Sales (MT) by Type (2015-2020)
Table 65. Japan Renal Anemia Treatment Sales Market Share by Type (2015-2020)
Table 66. Japan Renal Anemia Treatment Sales (MT) by Application (2015-2020)
Table 67. Japan Renal Anemia Treatment Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Renal Anemia Treatment Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Renal Anemia Treatment Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Renal Anemia Treatment Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Renal Anemia Treatment Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Renal Anemia Treatment Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Renal Anemia Treatment Sales Market Share by Application (2015-2020)
Table 74. India Renal Anemia Treatment Sales (MT) by Company (2015-2020)
Table 75. India Renal Anemia Treatment Sales Market Share by Company (2015-2020)
Table 76. India Renal Anemia Treatment Sales (MT) by Type (2015-2020)
Table 77. India Renal Anemia Treatment Sales Market Share by Type (2015-2020)
Table 78. India Renal Anemia Treatment Sales (MT) by Application (2015-2020)
Table 79. India Renal Anemia Treatment Sales Market Share by Application (2015-2020)
Table 80. Amgen Inc. Corporation Information
Table 81. Amgen Inc. Description and Business Overview
Table 82. Amgen Inc. Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Amgen Inc. Renal Anemia Treatment Product
Table 84. Amgen Inc. Recent Development
Table 85. F. Hoffmann-La Roche Ltd Corporation Information
Table 86. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 87. F. Hoffmann-La Roche Ltd Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. F. Hoffmann-La Roche Ltd Renal Anemia Treatment Product
Table 89. F. Hoffmann-La Roche Ltd Recent Development
Table 90. Pfizer Inc. Corporation Information
Table 91. Pfizer Inc. Description and Business Overview
Table 92. Pfizer Inc. Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Pfizer Inc. Renal Anemia Treatment Product
Table 94. Pfizer Inc. Recent Development
Table 95. Novartis AG Corporation Information
Table 96. Novartis AG Description and Business Overview
Table 97. Novartis AG Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Novartis AG Renal Anemia Treatment Product
Table 99. Novartis AG Recent Development
Table 100. Johnson & Johnson Services Inc. Corporation Information
Table 101. Johnson & Johnson Services Inc. Description and Business Overview
Table 102. Johnson & Johnson Services Inc. Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Services Inc. Renal Anemia Treatment Product
Table 104. Johnson & Johnson Services Inc. Recent Development
Table 105. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 106. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 107. Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Teva Pharmaceutical Industries Ltd. Renal Anemia Treatment Product
Table 109. Teva Pharmaceutical Industries Ltd. Recent Development
Table 110. AMAG Pharmaceuticals Corporation Information
Table 111. AMAG Pharmaceuticals Description and Business Overview
Table 112. AMAG Pharmaceuticals Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. AMAG Pharmaceuticals Renal Anemia Treatment Product
Table 114. AMAG Pharmaceuticals Recent Development
Table 115. Rockwell Medical Corporation Information
Table 116. Rockwell Medical Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Rockwell Medical Description and Business Overview
Table 118. Rockwell Medical Renal Anemia Treatment Product
Table 119. Rockwell Medical Recent Development
Table 120. Akebia Therapeutics Corporation Information
Table 121. Akebia Therapeutics Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Akebia Therapeutics Description and Business Overview
Table 123. Akebia Therapeutics Renal Anemia Treatment Product
Table 124. Akebia Therapeutics Recent Development
Table . Vifor Pharma Management Ltd. Corporation Information
Table . Vifor Pharma Management Ltd. Description and Business Overview
Table . Vifor Pharma Management Ltd. Renal Anemia Treatment Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Vifor Pharma Management Ltd. Renal Anemia Treatment Product
Table . Vifor Pharma Management Ltd. Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Renal Anemia Treatment Distributors List
Table 133. Renal Anemia Treatment Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Renal Anemia Treatment Product Picture
Figure 2. Global Renal Anemia Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Renal Anemia Treatment Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Research Institute Examples
Figure 9. Other Examples
Figure 10. Global Renal Anemia Treatment Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Renal Anemia Treatment Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Renal Anemia Treatment Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Renal Anemia Treatment Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Renal Anemia Treatment Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Renal Anemia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Renal Anemia Treatment Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Renal Anemia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Renal Anemia Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Renal Anemia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Renal Anemia Treatment Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Renal Anemia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Renal Anemia Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Renal Anemia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Renal Anemia Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Renal Anemia Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Renal Anemia Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Renal Anemia Treatment Players Market Share by Revenue in Renal Anemia Treatment 2015 & 2019
Figure 28. Renal Anemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Renal Anemia Treatment Revenue Share by Type (2015-2020)
Figure 30. Global Renal Anemia Treatment Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Renal Anemia Treatment Revenue Share by Application (2015-2020)
Figure 32. Global Renal Anemia Treatment Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Renal Anemia Treatment Sales Market Share by Type in 2019
Figure 34. United States Renal Anemia Treatment Sales Market Share by Type in 2019
Figure 35. Europe Renal Anemia Treatment Sales Market Share by Company in 2019
Figure 36. Europe Renal Anemia Treatment Sales Market Share by Type in 2019
Figure 37. Europe Renal Anemia Treatment Sales Market Share by Application in 2019
Figure 38. China Renal Anemia Treatment Sales Market Share by Company in 2019
Figure 39. China Renal Anemia Treatment Sales Market Share by Type in 2019
Figure 40. China Renal Anemia Treatment Sales Market Share by Application in 2019
Figure 41. Japan Renal Anemia Treatment Sales Market Share by Company in 2019
Figure 42. Japan Renal Anemia Treatment Sales Market Share by Type in 2019
Figure 43. Japan Renal Anemia Treatment Sales Market Share by Application in 2019
Figure 44. Southeast Asia Renal Anemia Treatment Sales Market Share by Company in 2019
Figure 45. Southeast Asia Renal Anemia Treatment Sales Market Share by Type in 2019
Figure 46. Southeast Asia Renal Anemia Treatment Sales Market Share by Application in 2019
Figure 47. India Renal Anemia Treatment Sales Market Share by Company in 2019
Figure 48. India Renal Anemia Treatment Sales Market Share by Type in 2019
Figure 49. India Renal Anemia Treatment Sales Market Share by Application in 2019
Figure 50. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Johnson & Johnson Services Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Rockwell Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Akebia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Vifor Pharma Management Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Renal Anemia Treatment
Figure 62. Manufacturing Process Analysis of Renal Anemia Treatment
Figure 63. Renal Anemia Treatment Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
後天性再生不良性貧血の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Acquired Aplastic Anemia market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Acquired Aplastic An…- 腎臓用治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Renal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 継続型腎代替療法（CRRT）マシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Continuous Renal Replacement Therapy (CRRT) Machine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- 継続型腎代替療法（CRRT）マシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Continuous Renal Replacement Therapy (CRRT) Machine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- バイオ人工腎補助装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Bioartificial Renal Assist Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …